Cafepharma Today

November 13 2024 - BioNTech to buy Biotheus, gaining control of cancer bispecific
BioNTech to buy Biotheus, gaining control of cancer bispecific
After election, FDA's Califf lays out hopes for his Trump-appointed successor
Hidden data on obesity prospect wipe $12B off Amgen market cap
London "is number one European city in life sciences"
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:
King Pharmaceuticals Bids $1.38 Billion for Alpharma
Bloomberg
Friday, August 22, 2008 - 9:30am
tags:
The Genentech Guessing Game - What Will Roche Offer Next?
Seeking Alpha
Thursday, August 21, 2008 - 9:02pm
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels
Eureka
In the Pipeline
Peptide Stability
In the Pipeline
How the Perfect Storm Will Impact Patient Support Programming in 2025 and Beyond
Drug Channels
The Choice Made
In the Pipeline
Just How Lipophilic Is That Huge Thing?
In the Pipeline
Down in the Mantle
In the Pipeline
Transparency Shocker: Biosimilars Are Getting Cheaper—But Hospitals and Insurers Can Make Them Expensive
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Neuroscience Account Manager (Psychiatry) - Newark, NJ
Newark, New Jersey, 07175
Vanda Pharmaceuticals
Territory Manager - Philadelphia S.
Oklahoma City, Oklahoma, 73116
FUJIFILM Corporation
Surgical Territory Manager - Miami, FL
Miami, Florida, 33222
Hologic
Neuroscience Account Manager (Psychiatry) - White Plains, NY
West Harrison, New York, 10604
Vanda Pharmaceuticals
Territory Manager (GI) (Youngstown, OH/Erie, PA)
Youngstown, Ohio, 44502
Bausch Health
Neuroscience Account Manager - Philadelphia West, PA
Philadelphia, Pennsylvania, 19117
Lundbeck
Account Manager- San Jose, CA- North
San Jose, California, 95199
Alcon MX
Psychiatry Account Manager - Long Branch, NJ
Long Branch, New Jersey, 07740
Lundbeck
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information